本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ASLAN PHARMACEUTICALS LIMITED SPON ADS EACH REP 25 ORD SHS (P/S)

0.6000
0.0000
成交量:- -
成交额:- -
市值:169.70万
市盈率:-0.04
高:0.6000
开:0.6000
低:0.6000
收:0.6000
52周最高:0.6000
52周最低:0.6000
股本:282.84万
流通股本:248.64万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-16.0948
每股收益(LYR):-21.5054
净资产收益率:-426.64%
总资产收益率:-53.69%
市净率:-0.09
市盈率(LYR):-0.03

数据加载中...

2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/04/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/23

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/31

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/04/16

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]